drugset / Trial / NCT01609920

Nodal Staging in Breast Cancer With MRL

NCT01609920

Terminated 97 enrolled Maastricht University Medical Center
NaSingle-groupOpen-labelDiagnostic

Summary

The aim of this study is to examine the diagnostic performance of gadofosveset enhanced magnetic resonance imaging lymphography (MRL). The diagnostic performance of MRL will be determined on the basis of a node-to-node matching of imaged nodes to the definitive histopathology. The pathologic examination of the sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND) will be regarded as the golden standard for nodal involvement.

Timeline

Start
2012-05
Primary completion
2016-05
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Gadofosveset Diagnostic / imaging agent 0.03 mmol Intravenous

Indications